BioMarin Pharmaceutical Inc. (0HNC.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 11.38B |
| Enterprise Value | 10.71B |
| P/E Ratio | 39.93 |
| PEG Ratio | -0.81 |
| Price/Sales Ratio | 3.33 |
| Price/Book Ratio | 1.73 |
| Enterprise/Revenue | 3.09 |
| Enterprise/EBITDA | 20.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.08 |
| Operating Margin | 0.14 |
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
| Revenue | 3.22B |
| Revenue/Share | 16.84 |
| Gross Profit | 2.48B |
| EBITDA | 613.03M |
| Net Income | 348.9M |
| Diluted EPS | 1.8 |
| Total Cash | 2.22B |
| Total Cash/Share | 11.55 |
| Total Debt | 1.45B |
| Total Debt/Equity | 0.23 |
| Current Ratio | 5.81 |
| Book Value Per Share | 32.27 |
| 52-Week Change | 2.85 |
| 52-Week High | 99.65 |
| 52-Week Low | 54.37 |
| Moving Average 50 Days | 90.32 |
| Moving Average 200 Days | 89.61 |
| Average Volume | 5,967 |
| Shares Outstanding | 178.06M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |